An Open-Label, Randomized, Parallel-Group Drug-Drug Interaction Study to Assess the Effect of Multiple Doses of Itraconazole or Gemfibrozil on the Pharmacokinetics of a Single Dose of JNJ-56021927 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2016
Price : $35 *
At a glance
- Drugs Apalutamide (Primary) ; Gemfibrozil; Itraconazole
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Aragon Pharmaceuticals; Janssen Research & Development
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
- 09 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 15 Sep 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.